WuXi Biologics beefs up its lobbying operation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Michelle McMurry-Heath re-emerges
Former BIO CEO Michelle McMurry-Heath has laid low since October 2022, following her abrupt exit from the organization. Recently, she’s re-emerged at some health care events with a new job title.
Read Original Article: WuXi Biologics beefs up its lobbying operation »
